Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations: 2010-2018

Historic Liabilities from Discontinued Operations for Sunshine Biopharma (SBFM) over the last 1 years, with Dec 2018 value amounting to $103,732.

  • Sunshine Biopharma's Liabilities from Discontinued Operations was N/A to $103,732 in Q4 2018 from the same period last year, while for Dec 2018 it was $103,732, marking a year-over-year change of. This contributed to the annual value of $103,732 for FY2018, which is N/A change from last year.
  • As of Q4 2018, Sunshine Biopharma's Liabilities from Discontinued Operations stood at $103,732, which was up 809.61% from $11,404 recorded in Q4 2010.
  • Sunshine Biopharma's 5-year Liabilities from Discontinued Operations high stood at $103,732 for Q4 2018, and its period low was $103,732 during Q4 2018.
  • Its 1-year average for Liabilities from Discontinued Operations is $103,732, with a median of $103,732 in 2018.